eEF1A1调节了与帕金森病相关的基因在U251细胞中的表达和替代拼接
Jing Lei1, Guliqiemu Aimaier1, Zaolaguli Aisha1
1Department of Neurology, The First Affiliated Hospital of Xinjiang Medical University, No. 137 Liyushan South Road, Xinshi District, Urumqi, Xinjiang, 830054, P.R. China.
Genes & genomics
|May 22, 2024
概括
细胞延长因子1A1 (eEF1A1) 与帕金森病 (PD) 病原发生有关. 它的失调影响基因表达和替代拼接,有助于PD的发展.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 细胞延长因子1A1 (eEF1A1) 是一种与PARK2活性相关的RNA结合蛋白.
- 这种关联表明eEF1A1在帕金森病 (PD) 发展中的潜在作用.
研究的目的:
- 研究eEF1A1在帕金森病 (PD) 中的作用.
- 为了确定eEF1A1是否通过转录或转录后调节影响PD.
主要方法:
- 分析了PD患者和对照患者的大脑组织的RNA-seq数据 (GSE68719数据集).
- 使用siRNA在U251细胞中击败eEF1A1表达.
- 执行RNA-seq以识别eEF1A1 knockdown后的差异表达基因 (DEG) 和替代拼接事件 (ASE).
主要成果:
- eEF1A1在PD脑组织的BA9区域显著过度表达.
- 击败eEF1A1改变了参与亡,炎症和线粒体功能障碍的基因的表达.
- 上调的特定基因包括CXCL10,NGF和IL6,而替代拼接变化影响了ACOT7和SHMT2.2等基因.
结论:
- eEF1A1在帕金森病 (PD) 的发展中起作用.
- 这一角色涉及调节差异性基因表达和替代拼接.
- 结果为未来的PD研究提供了理论基础.
相关概念视频
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
What is Gene Expression?
8.5K
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
8.5K
RNA Splicing
56.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Parkinson's Disease: Overview
528
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
528


